Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure
Appointed director

BIO-TECHNE Corp (TECH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4/A Bohnen Shane (SVP - General Counsel) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 148 restricted stock units @ $0
Granted 16,302 options to buy @ $84.61, valued at $1.4M
08/23/2023 10-K Annual Report for the period ended June 30, 2023
08/17/2023 4 Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 12,798 restricted stock units @ $0
Granted 34,442 options to buy @ $84.61, valued at $2.9M
Granted 45,923 options to buy @ $84.61, valued at $3.9M
08/17/2023 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 8,191 restricted stock units @ $0
Granted 22,043 options to buy @ $84.61, valued at $1.9M
Granted 29,391 options to buy @ $84.61, valued at $2.5M
08/17/2023 4 Bohnen Shane (SVP - General Counsel) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 4,432 restricted stock units @ $0
Granted 11,928 options to buy @ $84.61, valued at $1M
Granted 15,904 options to buy @ $84.61, valued at $1.3M
08/17/2023 4 Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Exercised 17,632 shares @ $0
Paid exercise price by delivering 8,675 shares @ $84.61, valued at $734k
Granted 59,095 restricted stock units @ $0
08/17/2023 4 Geist William (PRESIDENT, PROTEIN SCIENCES) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 8,377 restricted stock units @ $0
Granted 22,544 options to buy @ $84.61, valued at $1.9M
Granted 30,059 options to buy @ $84.61, valued at $2.5M
08/11/2023 4 Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Gifted 9,008 shares @ $0
08/08/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/08/2023 4 Hippel James (CFO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Paid exercise price by delivering 6,335 shares @ $82.17, valued at $520.5k
Exercised 12,876 restricted stock units @ $0
08/08/2023 4 Kelderman Kim (Pres. Diagnostics & Genom) has filed a Form 4 on BIO-TECHNE Corp
Txns: Paid exercise price by delivering 4,139 shares @ $82.17, valued at $340.1k
Exercised 8,060 restricted stock units @ $0
08/08/2023 8-K Quarterly results
Docs: "BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS",
". Future"
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 144 Form 144 - Report of proposed sale of securities:
07/05/2023 4 Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Paid exercise price by delivering 390,727 shares @ $81.63, valued at $31.9M
Exercised 616,676 options to buy @ $26.65, valued at $16.4M
06/09/2023 4 Kummeth Charles R. (CEO) has filed a Form 4 on BIO-TECHNE Corp
Txns: Sold 322 shares @ $83, valued at $26.7k
06/06/2023 144 Form 144 - Report of proposed sale of securities:
05/31/2023 SD Form SD - Specialized disclosure report:
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/03/2023 8-K Quarterly results
05/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2023 4 Bohnen Shane (SVP - General Counsel) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 6,778 restricted stock units @ $0
Granted 3,928 options to buy @ $73.76, valued at $289.7k
04/04/2023 3 Bohnen Shane (SVP - General Counsel) has filed a Form 3 on BIO-TECHNE Corp
04/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF"
03/01/2023 8-K Quarterly results
02/07/2023 10-Q Quarterly Report for the period ended December 31, 2022
02/02/2023 8-K Quarterly results
01/31/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL"
01/26/2023 SC 13G/A BlackRock Inc. reports a 10.1% stake in BIO-TECHNE CORPORATION
01/20/2023 SC 13G BlackRock Inc. reports a 10.1% stake in BIO-TECHNE CORPORATION
01/06/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/07/2022 10-Q Quarterly Report for the period ended September 30, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy